Where I see patients (1)
Selected research
- 
							Long-term outcomes of patients with mucopolysaccharidosis VI treated with galsulfase enzyme replacement therapy since infancy.
							Molecular genetics and metabolism
 - 
							Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy.
							Journal of inherited metabolic disease
 - 
							Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.
							Journal of inherited metabolic disease